Gene Therapies Market Report 2018: A Robust Pipeline with 985 In-Vivo Gene Therapies, and a Further 354 CART Cell Therapies Currently in Pipeline Development

February 21, 2018

Responsive image

DUBLIN, Feb. 21, 2018 /PRNewswire/ —
The “Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products such as Glybera and Strimvelis” report has been added to ResearchAndMarkets.com’s offering….

Category: Precious Metals